Furthermore, besides procurement of replacement tissues, haematopoietic stem cells and reproductive cells, some Member States also reported a significant number of procurement organisations carrying out procurement of tissue and cells to be used for manufacturing of advanced therapy medicinal products (ATMP) (Fig. 3).
Peale selle on mõned liikmesriigid teatanud, et lisaks koesiirikute, vereloome tüvirakkude ja sugurakkude hankimisele, tegeleb märkimisväärne arv hankimisasutusi kudede ja rakkude hankimisega uudsete ravimite tootmiseks (joonis 3).